Y1-17: Pharmacogenomic applications in the management of Non-Small Cell Lung Cancer (Nsclc) : from clinical trials to clinical practice
Simon, G.
Journal of Thoracic Oncology 2(8): S302-S304
2007
ISSN/ISBN: 1556-0864
DOI: 10.1097/01.jto.0000283085.25605.3f
Accession: 067584550
PDF emailed within 0-6 h: $19.90
Related References
Kuruvilla, P.G.; Krieger, H.; Zibdawi, L.; Meharchand, J.; Solow, H.; Leighl, N.; Chin, C.; Stewart, J.A.; Hollen, P.J.; Gralla, R.J. 2016: Assessing quality of life (QL) and patient reported outcomes (PROs) in clinical trials and clinical practice: A study using a hand-held computerized form of the validated LCSS instrument in patients with non-small cell lung cancer (NSCLC) Journal of Clinical Oncology 23(16_Suppl): 8067-8067Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2016: The influence of sex on efficacy, toxicity and delivery of treatment in National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) non-small cell lung cancer (NSCLC) chemotherapy trials Journal of Clinical Oncology 26(15_Suppl): 8054-8054
Koyi, H.; Hillerdal, G.; Kölbeck, K.-G.; Brodin, D.; Liv, P.; Brandén, E. 2016: Non-small Cell Lung Cancer (NSCLC) in Octogenarians in Clinical Practice Anticancer Research 36(10): 5397-5402
Lara, P.N.; Redman, M.W.; Kelly, K.; Edelman, M.J.; Williamson, S.K.; Crowley, J.J.; Gandara, D.R. 2016: Alternative measures predicting clinical benefit in advanced non-small cell lung cancer (NSCLC) from Southwest Oncology Group (SWOG) randomized trials: Implications for clinical trial design Journal of Clinical Oncology 24(18_Suppl): 7006-7006
Green, M.R.; Cox, J.D.; Ardizzoni, A.; Arriagada, R.; Bureau, G.; Darwish, S.; Deneffe, G.; Fukuoka, M.; Joseph, D.; Komaki, R. 1994: Endpoints for multimodal clinical trials in stage III non-small cell lung cancer (NSCLC): a consensus report Lung Cancer 11 Suppl. 3: S11-S13
Rocco, D.; Gregorc, V.; Della Gravara, L.; Lazzari, C.; Palazzolo, G.; Gridelli, C. 2020: New immunotherapeutic drugs in advanced non-small cell lung cancer (NSCLC): from preclinical to phase I clinical trials Expert Opinion on Investigational Drugs 29(9): 1005-1023
Bagai, R.K.; Dowlati, A. 2016: Evolution of statistical methodology and design of phase II/III clinical trials in non-small cell lung cancer (NSCLC) Journal of Clinical Oncology 24(18_Suppl): 7108-7108
Faehling, M.; Schwenk, B.; Kramberg, S.; Fallscheer, S.; Leschke, M.; Sträter, J.ör.; Eckert, R. 2018: Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice Journal of Cancer Research and Clinical Oncology 144(10): 2059-2066
Reungwetwattana, T.; Weroha, S.J.; Molina, J.R. 2012: Oncogenic pathways, molecularly targeted therapies, and highlighted clinical trials in non-small-cell lung cancer (NSCLC) Clinical lung cancer 13(4): 252-266
Mazzoni, F.; Rotella, V.; Pratesi, N.; Boni, L.; Simi, L.; Orlando, C.; Comin, C.E.; Maddau, C.; Di Costanzo, F. 2011: From clinical trials to clinical practice: predictors of response to erlotinib in advanced non-small cell lung cancer patients pretreated with chemotherapy Tumori 97(2): 160-165
Gironés, R.; Aparisi, F.; Sánchez, A.; GarcÃa, J.; Juan, Ã. 2017: P2.01-031 Use of Geriatric Assessment (Ga) in Clinical Practice for Stage Iv Non-Small Cell Lung Cancer (Nsclc). The Gido Experience Journal of Thoracic Oncology 12(11): S2080-S2081
Faehling, M.; Eckert, R.; Kuom, S.; Kamp, T.; Stoiber, K.; Kropf, C.; Rüdiger, S.; Schumann, C. 2009: Treatment of patients with advanced non-small-cell lung cancer (Nsclc) with erlotinib: results from clinical practice European Journal of Cancer Suppls 7(2): 550-551
Berghmans, T.; Meert, A-P.; Ninane, V.; Sculier, J-P. 2016: Implementation of clinical trials in unselected non-small cell lung cancer (NSCLC) patients: The mitomycin, ifosfamide, cisplatin (MIP) regimen Journal of Clinical Oncology 23(16_Suppl): 7287-7287
Park, S.; Lee, J.-C.; Choi, C.-M. 2021: Clinical Applications of Liquid Biopsy in Non-Small Cell Lung Cancer Patients: Current Status and Recent Advances in Clinical Practice Journal of Clinical Medicine 10(11)
Carrato, A.; Vergnenègre, A.; Thomas, M.; McBride, K.; Medina, J.; Cruciani, G. 2014: Clinical management patterns and treatment outcomes in patients with non-small cell lung cancer (NSCLC) across Europe: EPICLIN-Lung study Current Medical Research and Opinion 30(3): 447-461